Debug, a collective of scientists and engineers, is building a sterile‑mosquito program to curb disease‑carrying Aedes aegypti. The insects kill more humans than any other animal, spreading dengue, Zika, yellow fever and chikungunya to hundreds of millions annually. Conventional pesticides lose efficacy and pose toxicity risks, prompting a biologically‑based alternative.

The team releases male mosquitoes infected with the naturally occurring bacterium Wolbachia. Wolbachia prevents successful mating with wild females, so released males cannot produce offspring and do not bite. Because the approach relies on a symbiotic microbe rather than chemicals or genetic edits, it avoids regulatory hurdles and leverages a technique already proven against other pests.

Debug is field‑testing its rearing and release protocols in partnership with local scientists, governments and community groups. Early pilots target Aedes aegypti hotspots, aiming to suppress populations enough to lower transmission rates. The organization plans to scale deployments once production capacity reaches the levels needed to impact millions of residents.

By avoiding toxins and genetic modification, Debug’s method aligns with public‑health goals and eases community acceptance. If releases achieve sustained suppression, the model could be replicated in other endemic regions, offering a scalable, low‑cost tool against mosquito‑borne illnesses worldwide for health agencies and NGOs globally.